Case Report | Open Access
Navdeep Singh, Kenneth Washburn, Sylvester Black, Austin Schenk, "Techniques for Management of Portal Vein Thrombosis during Liver Transplantation", Case Reports in Transplantation, vol. 2020, Article ID 8875196, 4 pages, 2020. https://doi.org/10.1155/2020/8875196
Techniques for Management of Portal Vein Thrombosis during Liver Transplantation
Portal vein thrombosis (PVT) poses a unique challenge in liver transplant. The management of PVT differs according to the extent of thrombosis. Anastomosis of a donor portal vein to a varix is a viable option when an adequate size varix is identified on preoperative imaging or intraoperatively. Here, we describe our experience in two liver transplant cases with cavernous transformation of the portal vein where the donor portal vein was anastomosed to a varix using a donor iliac vein interposition graft.
In 1985, Shaw and colleagues described successful liver transplantation in seven patients with severely reduced or absent portal flow, and since that time, portal vein thrombosis (PVT) has no longer been considered an absolute contraindication to liver transplantation . PVT is reported in 5-26% of liver transplants . As fibrosis develops in the failing liver, antegrade portal flow is impeded, hepatofugal flow develops, and varices mature. Acute PVT is typically symptomatic, but chronic PVT remains asymptomatic as collateral varices slowly develop over time. Preoperative ultrasound and/or three-dimensional imaging is used to detect PVT and facilitate operative planning. Yerdel and colleagues  proposed an anatomic classification system which defined aberrancies in portal flow as (a) <50% occlusion of the portal vein, (b) >50% occlusion of the portal vein (including complete occlusion), (c) complete thrombosis of both the portal vein and proximal superior mesenteric vein (SMV), and (d) complete thrombosis of the portal vein and both the proximal and the distal SMV. Each of these scenarios requires advanced planning and creative surgical techniques. Here, we describe our recent experience with two cases of complete PVT (so-called cavernous transformation) in which alternate portal inflow was established from large intra-abdominal varices (varicoportal anastomosis, VPA).
1.1. Case 1
Our first patient was a 58-year-old male with primary biliary cirrhosis and nonalcoholic steatohepatitis. Portal flow was not visualized on preoperative Doppler ultrasound. Contrast enhanced CT demonstrated complete PVT with cavernous transformation (Figure 1(a)) and clot extending into the distal SMV. A large splenorenal shunt and large upper abdominal varices were noted (Figure 1(b)). Intraoperatively, a large left upper quadrant varix was identified as the target portal inflow vessel prior to the hepatectomy. As predicted, the portal vein was completely atretic and without flow, and there were numerous collaterals in the porta hepatis. Once anhepatic, a Satinsky clamp was placed on the target varix and a segment of donor ileac vein was sewn end-to-side to the varix using 6-0 Prolene. No attempt was made to encircle or otherwise dissect the varix. When the anastomosis was complete, the vein graft was occluded distally and the Satinsky was removed. Flow in the conduit was satisfactory, but to further augment portal flow, the left renal vein was ligated. Implantation was then completed with end-to-end anastomosis of the ileac vein jump graft to the donor portal vein. Allograft function was excellent.
1.2. Case 2
Our second case was a 61-year-old male with cryptogenic cirrhosis and hepatocellular carcinoma. Preoperative imaging revealed cavernous transformation with numerous portal venous collaterals most prominent in the paraesophageal (Figure 2(a)) and perigastric regions (Figure 2(b)). The left renal vein was nondilated, and a splenorenal shunt was not present. Variant portal inflow was created by joining an ileac vein graft to a large perigastric varix (Figures 2(c)–2(f)). Portal flow and hepatic function were excellent.
Portal vein thrombosis can range from mild partial nonocclusive thrombus to complete occlusion with cavernous transformation, and varied surgical techniques are required to handle each scenario . Quality preoperative ultrasound and three-dimensional imaging are essential for operative planning. In cases where PV thrombosis is known preoperatively, we deliberately select younger brain dead donors with minimal steatosis for these recipients, and we utilize the following options to establish portal inflow: (1)Intraoperative portal vein thrombovenectomy(2)SMV jump grafting(3)Establishing renal-portal inflow from left renal vein and donor ileac vein conduit(4)Varix-to-portal anastomoses with or without conduit(5)Portacaval transposition
In all cases, we consider left renal vein ligation or ligation of other collateral vessels to enhance portal inflow. Preoperative IR-guided portal vein recanalization has been described , as has arterialization of portal inflow , though we have not utilized these techniques in our practice. We have combined all of the stated variants with piggyback implantation technique, and once robust portal inflow is established, it has not been our practice to use postoperative anticoagulation aside from low-dose aspirin.
Physiologic portal inflow is associated with better 1-, 5-, and 10-year outcomes than any alternative described , and therefore, PV thrombectomy and primary anastomosis are the procedures of choice whenever possible . When the entire portal vein is unusable, dissection can be carried to the junction of the SMV and splenic veins . When the thrombus extends beyond the splenomesenteric junction, a venous jump graft is sewn to the main trunk of the SMV. When the SMV is unusable, a high flow splenorenal shunt may allow for renal-portal anastomosis. Ideal portal inflow is described as 100 mL of flow per minute per 100 gm of liver tissue, and renal-portal techniques have been reported to provide up to 900 mL/min of flow [10, 11]. When renal-portal anastomosis is not possible, consideration is given to VPA. Use of pericholedochal and peripancreatic varices has been reported [12–14]. Alexopoulos and colleagues report 100% patient survival and good allograft function in 5 patients treated with VPA with a median follow-up of 2.3 years . Portacaval transposition and arterialization of the portal vein are considered last resort measures and are frequently associated with need for retransplantation.
In summary, successful surgical management of PVT requires preoperative imaging, thoughtful planning, surgical creativity, and adherence to a practice-based algorithm for establishing portal inflow.
Conflicts of Interest
The authors declare no conflicts of interest.
Navdeep Singh and Austin Schenk were responsible for writing and editing this case report. Kenneth Washburn and Sylvester Black were responsible for editing this case report.
- B. W. Shaw, S. Iwatsuki, K. Bran, and T. E. Starzl, “Portal vein grafts in hepatic transplantation,” Surgery Gynecology and Obstetrics, vol. 161, no. 1, pp. 66–68, 1985.
- C. Francoz, D. Valla, and F. Durand, “Portal vein thrombosis, cirrhosis, and liver transplantation,” Journal of Hepatology, vol. 57, no. 1, pp. 203–212, 2012.
- M. A. Yerdel, B. Gunson, D. Mirza et al., “Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome,” Transplantation, vol. 69, no. 9, pp. 1873–1881, 2000.
- A. C. Stieber, G. Zetti, S. Todo et al., “The spectrum of portal vein thrombosis in liver transplantation,” Annals of Surgery, vol. 213, no. 3, pp. 199–206, 1991.
- R. Salem, M. Vouche, T. Baker et al., “Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis,” Transplantation, vol. 99, no. 11, pp. 2347–2355, 2015.
- P. Bhangui, C. Salloum, C. Lim et al., “Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience,” HPB: The Official Journal of the International Hepato Pancreato Biliary Association, vol. 16, no. 8, pp. 723–738, 2014.
- T. Hibi, S. Nishida, D. M. Levi et al., “When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases,” Annals of Surgery, vol. 259, no. 4, pp. 760–766, 2014.
- R. Robles, J. A. Fernandez, Q. Hernandez et al., “Eversion thromboendovenectomy in organized portal vein thrombosis during liver transplantation,” Clinical Transplantation, vol. 18, no. 1, pp. 79–84, 2004.
- R. D. Gordon, “Liver transplantation and venous disorders of the liver,” Liver Transplantation and Surgery, vol. 3, 5 Supplement 1, pp. S41–S51, 1997.
- A. L. Spitzer, A. A. S. Dick, R. Bakthavatsalam et al., “Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation,” HPB: The Official Journal of the International Hepato Pancreato Biliary Association, vol. 12, no. 3, pp. 166–173, 2010.
- H. J. Kowalski and W. H. Abelmann, “The cardiac output at rest in Laennec's cirrhosis,” The Journal of Clinical Investigation, vol. 32, no. 10, pp. 1025–1033, 1953.
- D. Germanova, V. Lucidi, A. Buggenhout et al., “Liver transplantation in cases of portal vein thrombosis in the recipient: a case report and review of the various options,” Transplantation Proceedings, vol. 43, no. 9, pp. 3490–3492, 2011.
- D.-B. Moon, S.-G. Lee, C.-S. Ahn et al., “Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis,” Liver Transplantation, vol. 20, no. 5, pp. 612–615, 2014.
- M. Ravaioli, M. Zanello, G. L. Grazi et al., “Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna,” Annals of Surgery, vol. 253, no. 2, pp. 378–384, 2011.
- S. P. Alexopoulos, E. Thomas, E. Berry, G. Whang, and L. Matsuoka, “The portal vein-variceal anastomosis: an important technique for establishing portal vein inflow,” Clinical Transplantation, vol. 28, no. 1, pp. 52–57, 2014.
Copyright © 2020 Navdeep Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.